Open AccessBuprenorphine for the Treatment of the Neonatal Abstinence Syndrome
Author(s) -
Walter K. Kraft,
Susan Adeniyi-Jones,
Inna Chervoneva,
Jay S. Greenspan,
Diane J. Abatemarco,
Karol Kaltenbach,
Michelle E. Ehrlich
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1614835
Subject(s) - medicine , buprenorphine , abstinence , narcotic antagonists , psychiatry , anesthesia , opioid , (+) naloxone , receptor
Current pharmacologic treatment of the neonatal abstinence syndrome with morphine is associated with a lengthy duration of therapy and hospitalization. Buprenorphine may be more effective than morphine for this indication.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom